- Home
- ICUI vs FROG Comparison
ICUI vs FROG Comparison
Compare ICUI & FROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUI
- FROG
- Stock Information
- Founded
- ICUI 1984
- FROG 2008
- Country
- ICUI United States
- FROG United States
- Employees
- ICUI N/A
- FROG N/A
- Industry
- ICUI Medical/Dental Instruments
- FROG Computer Software: Prepackaged Software
- Sector
- ICUI Health Care
- FROG Technology
- Exchange
- ICUI Nasdaq
- FROG Nasdaq
- Market Cap
- ICUI 3.4B
- FROG 3.6B
- IPO Year
- ICUI 1992
- FROG 2020
- Fundamental
- Price
- ICUI $134.86
- FROG $42.94
- Analyst Decision
- ICUI Strong Buy
- FROG Strong Buy
- Analyst Count
- ICUI 5
- FROG 19
- Target Price
- ICUI $196.75
- FROG $40.44
- AVG Volume (30 Days)
- ICUI 283.6K
- FROG 1.2M
- Earning Date
- ICUI 05-08-2025
- FROG 05-08-2025
- Dividend Yield
- ICUI N/A
- FROG N/A
- EPS Growth
- ICUI N/A
- FROG N/A
- EPS
- ICUI N/A
- FROG N/A
- Revenue
- ICUI $2,420,093,000.00
- FROG $450,584,000.00
- Revenue This Year
- ICUI N/A
- FROG $19.79
- Revenue Next Year
- ICUI N/A
- FROG $15.33
- P/E Ratio
- ICUI N/A
- FROG N/A
- Revenue Growth
- ICUI 7.22
- FROG 21.66
- 52 Week Low
- ICUI $101.44
- FROG $22.91
- 52 Week High
- ICUI $196.26
- FROG $43.79
- Technical
- Relative Strength Index (RSI)
- ICUI 48.47
- FROG 70.56
- Support Level
- ICUI $127.91
- FROG $41.89
- Resistance Level
- ICUI $135.62
- FROG $43.47
- Average True Range (ATR)
- ICUI 4.35
- FROG 1.31
- MACD
- ICUI -0.26
- FROG -0.08
- Stochastic Oscillator
- ICUI 33.77
- FROG 80.68
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
About FROG JFrog Ltd.
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from Israel and also has its presence in United States, India and other regions.